**About the Editors**

**Rinaldo Pellicano** (MD) is a Gastroenterologist at Molinette Hospital and San Giovanni Antica Sede (SGAS) Outpatient Clinic (Azienda Ospedaliero-Universitaria Citta della Salute e della Scienza) ` in Turin, Italy. He obtained his specialist degree in Gastroenterology and Digestive Endoscopy at the University of Turin. His main research activities are related to 1) the characterization and role of microbioma in gastrointestinal and extra-gastrointestinal diseases 2) the role of Helicobacter pylori infection in the pathogenesis of gastroduodenal and extra-gastroduodenal manifestations; 3) the cure of Helicobacter pylori infection with conventional and innovative treatments; 4) possible association between occult HCV infection and cryptogenic chronic hepatitis; 5) cure of patients with chronic hepatitis of viral and non-viral etiology; 6) cure of patients with inflammatory bowel diseases. Dr. Pellicano has been appointed as lecturer for several courses at the University of Turin, including Management of Inflammatory Bowel Diseases (Master of Coloproctology). He performs numerous editorial duties, such as 1) Chief Editor of Minor Gastroenterology; 2) Subspeciality Editor of Minerva Medica and PanMinerva Medica; 3) Editorial Board Member of several journals, including Medicina; World Journal of Gastroenterology; International Journal of Celiac Disease; Medicines; Biomedical Research and Therapy; 4) reviewer of several scientific journals. His scientific publications can be found on PubMed (https://pubmed.ncbi.nlm.nih.gov/?term=Pellicano+Rinaldo&size=200) and his books and chapters on his webpage (http://rinaldopellicano.blogspot.com/).

**Sharmila Fagoonee** (PhD) is a Researcher at the Institute of Biostructure and Bioimaging of the Italian National Research Council and Molecular Biotechnology Center in Turin, Italy. After her BSc (hons) in Biology in Mauritius and MSc in Cellular Biology in Bordeaux, France, she go<sup>t</sup> her PhD in Cell and Molecular Biology at the University of Turin. She has been appointed as a lecturer for courses on Regenerative Medicine at the University of Turin regarding the master's course in Stem Cells and Regenerative Medicine and Cell Factory Management, Advanced Training Course in Regenerative Medicine, Italian Regenerative Medicine Infrastructure—IRMI, and Cell Biology courses for the MSc in Molecular Biotechnology. Using a multidisciplinary approach including advanced molecular techniques such as RNA-seq and large-scale proteomics, as well as in vitro and in vivo studies, her two main current research areas regard 1) regenerative medicine: adult stem cells-based therapy for human metabolic diseases; identify circulating extracellular vesicles-based biomarkers for the early diagnosis of liver fibrosis, and for predicting the progression of liver fibrosis to hepatocellular carcinoma; evaluation of nephropathy arising from cholestasis. 2) Post-transcriptional regulation of gene expression, in particular investigating the molecular mechanisms underlying the role of the RNA binding proteins and splicing factors, ESRP1 and 2, in human diseases. As part of her editorial activities, she has been recently appointed as Chief Editor of Minerva Biotechnology and Biomolecular Research and is an Editorial Board Member of Journal of Clinical Medicine; World Journal of Gastroenterology and Biomedical Research and Therapy, as well as a reviewer of several journals.
